LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Joan Albanell ,F Rojo Todo,S Bezares Montes,I Garau Llinas,Miriam O Connor ,Alfonso Sánchez Muñoz ,M Martinez ,Luis De La Cruz-Merino ,Juan De La Haba Rodriguez ,Ana Santaballa Bertrán ,Mireia Margelí Vila ,Isaura Fernández Pérez ,M Ramos ,Fernando Moreno ,Noelia Martínez-Jáñez ,Lucía González-Cortijo ,María Isabel Casas ,Pedro Sánchez‐Rovira ,Juan Antonio Virizuela Echaburu

doi:10.1016/j.annonc.2020.08.2247

LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Joan Albanell , F Rojo Todo + Show 17 more

Open Access

https://doi.org/10.1016/j.annonc.2020.08.2247

Copy DOI

Journal: Annals of Oncology	Publication Date: Sep 1, 2020
Citations: 3	License type: elsevier-specific: oa user license

Affiliation: Municipal Institute for Medical Research, GEICAM – Spanish Breast Cancer Group, Centro de Investigación Biomédica en Red de Cáncer, Hospital del Mar Research Institute, Hospital Universitario Fundación Jiménez Díaz, Instituto de Salud Carlos III, Hospital Son Llatzer, Cancer Trials Ireland, University Hospital Waterford, Centro Oncológico de Galicia, Hospital Universitari Germans Trias i Pujol, Hospital Universitario Ramón y Cajal, Complejo Hospitalario de Jaén

#First-line Therapy In Postmenopausal Women #Therapy In Postmenopausal Women + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.